| |
|
|
|
Intec Pharma Ltd.  
|
|
6.7 -0.25 (-0.04%) |
03-22 16:00 |
|
Open: |
6.94 |
Pre close: |
6.95 |
Target:
|
9.60
|
|
High: |
7 |
Low: |
6.7 |
Resistance:
|
8.22
9.25
|
|
Volume: |
140,737 |
Market Cap: |
223M |
Support:
|
6.55
5.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.80
 |
MACD |
MACD(12,26):
|
-0.38 |
|
MA(20): |
7.57 |
Signal(12,26,9): |
-0.30 |
|
MA(100): |
7.28  |
Stochastic Oscillator |
%K(14,3):
|
10.46 |
|
MA(250): |
5.74 |
%D(3): |
10.96 |
|
Average Volume(K) |
3-Month: |
26229
|
52-Week |
High:
|
9.25 |
|
10-Days: |
27902 |
Low: |
3.55 |
|
RSI |
RSI(14):
|
36.86 |
Change(%): |
5.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.410 |
Return on Equity (ttm) |
-77.5 |
Shares Out. (M) |
33.23 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-69.1 |
Shares Float (M) |
33.04 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.60 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.60 |
|
Forward EPS |
-1.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.180 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.60 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-39.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-27.61 |
P/CF |
-5.70 |
|
|
|
|
|
|
